Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?
about
Spatiotemporal expression of chemokines and chemokine receptors in experimental anti-myeloperoxidase antibody-mediated glomerulonephritis.Differential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177.ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis Linked with Non-Small Cell Carcinoma of the Lung.Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration.Endothelium-neutrophil interactions in ANCA-associated diseasesCirculating ADAM17 Level Reflects Disease Activity in Proteinase-3 ANCA-Associated VasculitisRelationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis.Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis.Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitisPlasma Ang2 and ADAM17 levels are elevated during clinical malaria; Ang2 level correlates with severity and expression of EPCR-binding PfEMP1.Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review.Biologics for the treatment of autoimmune renal diseases.AP-VAS 2012 case report: a case of ANCA-negative pauci-immune crescentic glomerulonephritis associated with IL-6-producing adenosquamous cell carcinoma of the lung.A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy.IL-26 Confers Proinflammatory Properties to Extracellular DNA.Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation.Neutrophils from vasculitis patients exhibit an increased propensity for activation by anti-neutrophil cytoplasmic antibodies.Corticosteroid-free treatment of tocilizumab monotherapy for microscopic polyangiitis: a single-arm, single-center, clinical trial.Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism.Monocyte Chemoattractant Protein-1 in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Biomarker Potential and Association with Polymorphisms in the MCP-1 and the CC Chemokine Receptor-2 Gene.
P2860
Q33500805-7085988A-708C-4958-97A5-CFBDAA1C583EQ33753741-217497B6-7882-48B3-ABE8-EB5C451F7D70Q35901670-B67772C1-9380-4452-B5E1-436FBCBF0C90Q35907799-28EEFCDB-08FE-4796-8F21-8C4402379E88Q36200937-B4DAE9FD-28D9-4D01-9C40-80880FF2E780Q36223254-54450C96-3528-41F8-A0E1-A264C4462109Q36843060-3ECD807E-429C-4847-9895-E369F0B1D67AQ37170453-975FD8E4-F731-4959-B2A7-FF4686CD62D7Q37251182-682ED08A-6931-407A-A702-AA46A84B816AQ37370672-1656A761-A6A2-49F1-9CBA-E428BE4F2A8FQ38653449-1E20BB05-EAFE-44A9-B84D-6CD3AAE7132DQ38763327-4F9045EF-9369-4826-B248-C30C042FD59FQ38783522-7D819046-AE79-4A11-AEDA-BD9BCEF96DEFQ39317812-EB1F3A64-3C22-44E5-8636-64ABE841892AQ40273155-2EE7A7C4-00EA-4747-AB6A-A23120039076Q43162050-C24D17FE-E5B9-4443-AC35-BFFF27F8804CQ46914738-5860AD75-E40E-472D-BC29-6AA508860C1DQ50700806-24038B25-A0BF-4981-9BD2-043B5389E458Q53428119-B5059035-3104-49D0-9842-6DF283B6B598Q54595726-C7624DCB-5868-487F-8C25-258670F8A2EBQ55401446-133C77B5-1B4C-4FA7-BBE9-669744DF50D9
P2860
Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Circulating cytokine profile i ...... ulitis: prediction of outcome?
@ast
Circulating cytokine profile i ...... ulitis: prediction of outcome?
@en
type
label
Circulating cytokine profile i ...... ulitis: prediction of outcome?
@ast
Circulating cytokine profile i ...... ulitis: prediction of outcome?
@en
prefLabel
Circulating cytokine profile i ...... ulitis: prediction of outcome?
@ast
Circulating cytokine profile i ...... ulitis: prediction of outcome?
@en
P2093
P2860
P1476
Circulating cytokine profile i ...... ulitis: prediction of outcome?
@en
P2093
Jörgen Wieslander
Mårten Segelmark
Sophie Ohlsson
P2860
P304
P356
10.1080/09629350400003100
P577
2004-08-01T00:00:00Z